Aswini A Balachandran1, Swapna Duvalla1, Abdul H Sultan1, Ranee Thakar2. 1. Department of Obstetrics and Gynaecology, Croydon University Hospital, 530 London Road, London, CR7 7YE, UK. 2. Department of Obstetrics and Gynaecology, Croydon University Hospital, 530 London Road, London, CR7 7YE, UK. Ranee.Thakar@nhs.net.
Abstract
INTRODUCTION AND HYPOTHESIS: Female genital mutilation (FGM) has been associated with adverse obstetric and neonatal outcomes, such as postpartum haemorrhage (PPH), perineal trauma, genital fistulae, obstructed labour and stillbirth. The prevalence of FGM has increased in the UK over the last decade. There are currently no studies available that have explored the obstetric impact of FGM in the UK. The aim of our study was to investigate the obstetric and neonatal outcomes of women with FGM when compared with the general population. METHODS: We conducted a retrospective case-control study of consecutive pregnant women with FGM over a 5-year period between 1 January 2009 and 31 December 2013. Each woman with FGM was matched for age, ethnicity, parity and gestation with subsequent patients without FGM (control cohort) over the same 5-year period. Outcomes assessed were mode of delivery, duration of labour, estimated blood loss, analgaesia, perineal trauma and foetal outcomes. RESULTS: A total of 242 eligible women (121 FGM, 121 control) were identified for the study. There was a significant increase in the use of episiotomy in the FGM group (p = 0.009) and a significant increase in minor PPH in the control group during caesarean sections (p = 0.0001). There were no differences in all other obstetric and neonatal parameters. CONCLUSIONS: In our unit, FGM was not associated with an increased incidence of adverse obstetric and foetal morbidity or mortality.
INTRODUCTION AND HYPOTHESIS: Female genital mutilation (FGM) has been associated with adverse obstetric and neonatal outcomes, such as postpartum haemorrhage (PPH), perineal trauma, genital fistulae, obstructed labour and stillbirth. The prevalence of FGM has increased in the UK over the last decade. There are currently no studies available that have explored the obstetric impact of FGM in the UK. The aim of our study was to investigate the obstetric and neonatal outcomes of women with FGM when compared with the general population. METHODS: We conducted a retrospective case-control study of consecutive pregnant women with FGM over a 5-year period between 1 January 2009 and 31 December 2013. Each woman with FGM was matched for age, ethnicity, parity and gestation with subsequent patients without FGM (control cohort) over the same 5-year period. Outcomes assessed were mode of delivery, duration of labour, estimated blood loss, analgaesia, perineal trauma and foetal outcomes. RESULTS: A total of 242 eligible women (121 FGM, 121 control) were identified for the study. There was a significant increase in the use of episiotomy in the FGM group (p = 0.009) and a significant increase in minor PPH in the control group during caesarean sections (p = 0.0001). There were no differences in all other obstetric and neonatal parameters. CONCLUSIONS: In our unit, FGM was not associated with an increased incidence of adverse obstetric and foetal morbidity or mortality.
Authors: Osanna Yee Ki Wan; Annika Taithongchai; Susana I Veiga; Abdul H Sultan; Ranee Thakar Journal: Int Urogynecol J Date: 2020-07-02 Impact factor: 2.894
Authors: Issa Rashid Suleiman; Eusebious Maro; Benjamin C Shayo; Julius Pius Alloyce; Gileard Masenga; Michael J Mahande; Bariki Mchome Journal: PLoS One Date: 2021-01-06 Impact factor: 3.240
Authors: David Tordrup; Chrissy Bishop; Nathan Green; Max Petzold; Fernando Ruiz Vallejo; Joshua P Vogel; Christina Pallitto Journal: BMJ Glob Health Date: 2022-02